{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:29:08Z","timestamp":1792290548634,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200652"],"award-info":[{"award-number":["82200652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJZD-K202301605"],"award-info":[{"award-number":["KJZD-K202301605"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX5364"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX5364"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009587","name":"Chongqing University of Education","doi-asserted-by":"publisher","award":["KY202121C"],"award-info":[{"award-number":["KY202121C"]}],"id":[{"id":"10.13039\/501100009587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jhep.2024.08.029","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:31:42Z","timestamp":1725939102000},"page":"277-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression"],"prefix":"10.1016","volume":"82","author":[{"given":"Minxuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liancai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bochu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.08.029_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella Mary","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2024.08.029_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"10382","key":"10.1016\/j.jhep.2024.08.029_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","article-title":"Contemporary medical, device, and surgical therapies for obesity in adults","volume":"401","author":"Perdomo","year":"2023","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.jhep.2024.08.029_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhep.2024.08.029_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.08.029_bib6","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (NASH)\u2013A review of a crowded clinical landscape, driven by a complex disease","author":"Fraile","year":"2021","journal-title":"Drug Des Dev Ther"},{"issue":"9","key":"10.1016\/j.jhep.2024.08.029_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037961","article-title":"Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease","volume":"10","author":"Kessoku","year":"2020","journal-title":"BMJ open"},{"issue":"10215","key":"10.1016\/j.jhep.2024.08.029_bib8","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.08.029_bib10","article-title":"FDA approves first treatment for patients with liver scarring due to fatty liver disease","volume":"EB\/OL","year":"2024","journal-title":"FDA"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib11","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1038\/s41467-021-27038-5","article-title":"Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation","volume":"12","author":"Ryzhakov","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jhep.2024.08.029_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105696","article-title":"Mouse modeling dissecting macrophage\u2013breast cancer communication uncovered roles of PYK2 in macrophage recruitment and breast tumorigenesis","volume":"9","author":"M\u00fcller","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.jhep.2024.08.029_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00762-7","article-title":"Calcium signaling in hepatitis B virus infection and its potential as a therapeutic target","volume":"19","author":"Kong","year":"2021","journal-title":"Cell Commun Signaling"},{"key":"10.1016\/j.jhep.2024.08.029_bib14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00018-015-2100-2","article-title":"Metabolic changes associated with tumor metastasis, part 2: mitochondria, lipid and amino acid metabolism","volume":"73","author":"Porporato","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"10.1016\/j.jhep.2024.08.029_bib15","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14958","article-title":"Crosstalk between beta-adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high-fat diet-fed male mice","volume":"9","author":"Ashraf","year":"2021","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib16","article-title":"Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis","volume":"10","author":"Kim","year":"2020","journal-title":"Scientific Rep"},{"issue":"5","key":"10.1016\/j.jhep.2024.08.029_bib17","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/hep.24562","article-title":"Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase\/extracellular signal-regulated kinase\/matrix metalloproteinase-9 axis","volume":"54","author":"Jia","year":"2011","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.jhep.2024.08.029_bib18","doi-asserted-by":"crossref","first-page":"21129","DOI":"10.1074\/jbc.M500898200","article-title":"Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating \u03b2-catenin tyrosine phosphorylation","volume":"280","author":"Van Buul","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.jhep.2024.08.029_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bph.14094","article-title":"Up-regulation of PYK2\/PKC\u03b1-dependent haem oxygenase-1 by CO-releasing molecule-2 attenuates TNF-\u03b1-induced lung inflammation","volume":"175","author":"Lin","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"20","key":"10.1016\/j.jhep.2024.08.029_bib20","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1111\/bph.14465","article-title":"Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPAR\u03b3 attenuates LPS-mediated lung inflammation","volume":"175","author":"Cho","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/JLB.3MIR1118-417R","article-title":"Cells under stress: the mechanical environment shapes inflammasome responses to danger signals","volume":"106","author":"Joshi","year":"2019","journal-title":"J\u00a0Leukoc Biol"},{"issue":"3","key":"10.1016\/j.jhep.2024.08.029_bib22","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1042\/BJ20080133","article-title":"Calcium-dependent Pyk2 activation: a role for calmodulin?","volume":"410","author":"Schaller","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2024.08.029_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.749001","article-title":"The non-receptor tyrosine kinase Pyk2 in brain function and neurological and psychiatric diseases","volume":"13","author":"de Pins","year":"2021","journal-title":"Front Synaptic Neurosci"},{"issue":"3","key":"10.1016\/j.jhep.2024.08.029_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.118.038891","article-title":"Orai1 channel inhibition preserves left ventricular systolic function and normal Ca2+ handling after pressure overload","volume":"141","author":"Bartoli","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.0105-2896.2005.00335.x","article-title":"The role (s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function","volume":"208","author":"Horne","year":"2005","journal-title":"Immunological Rev"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/15548627.2022.2070331","article-title":"Multifaceted roles of TAX1BP1 in autophagy","volume":"19","author":"White","year":"2023","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.jhep.2024.08.029_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2024.08.029_bib29","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/hep.32526","article-title":"Tripartite motif-containing protein 31 confers protection against nonalcoholic steatohepatitis by deactivating mitogen-activated protein kinase kinase kinase 7","volume":"77","author":"Xu","year":"2023","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhep.2024.08.029_bib31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1080\/13543784.2020.1839888","article-title":"The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success","volume":"29","author":"Drenth","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"10.1016\/j.jhep.2024.08.029_bib32","first-page":"501","article-title":"FDA rejects NASH drug","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.jhep.2024.08.029_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41467-022-28641-w","article-title":"The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes","volume":"13","author":"Xu","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jhep.2024.08.029_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018878","article-title":"Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition","volume":"6","author":"Sun","year":"2011","journal-title":"PloS one"},{"issue":"17","key":"10.1016\/j.jhep.2024.08.029_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95332","article-title":"CF airway smooth muscle transcriptome reveals a role for PYK2","volume":"2","author":"Cook","year":"2017","journal-title":"JCI insight"},{"issue":"5","key":"10.1016\/j.jhep.2024.08.029_bib37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.10.041","article-title":"Loss of TAX1BP1-directed autophagy results in protein aggregate accumulation in the brain","volume":"80","author":"Sarraf","year":"2020","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.jhep.2024.08.029_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-020-2658-y","article-title":"Mitochondrial dysfunction generates aggregates that resist lysosomal degradation in human breast cancer cells","volume":"11","author":"Biel","year":"2020","journal-title":"Cell Death Dis"},{"issue":"16","key":"10.1016\/j.jhep.2024.08.029_bib39","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.scib.2021.01.030","article-title":"TAX1BP1 protects against myocardial infarction-associated cardiac anomalies through inhibition of inflammasomes in a RNF34\/MAVS\/NLRP3-dependent manner","volume":"66","author":"Xu","year":"2021","journal-title":"Sci Bull"},{"issue":"7","key":"10.1016\/j.jhep.2024.08.029_bib40","first-page":"347","article-title":"TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond","volume":"36","author":"Verstrepen","year":"2011","journal-title":"Trends Biochemical Sciences"},{"issue":"5","key":"10.1016\/j.jhep.2024.08.029_bib41","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.bbadis.2018.02.012","article-title":"TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy","volume":"1864","author":"Xiao","year":"2018","journal-title":"Biochim Biophys Acta (BBA)-Molecular Basis Dis"},{"issue":"20","key":"10.1016\/j.jhep.2024.08.029_bib42","doi-asserted-by":"crossref","first-page":"14999","DOI":"10.1074\/jbc.M110.109819","article-title":"TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases","volume":"285","author":"Parvatiyar","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.jhep.2024.08.029_bib43","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1038\/s41401-022-00950-2","article-title":"Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis","volume":"43","author":"Wu","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"issue":"9","key":"10.1016\/j.jhep.2024.08.029_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ni.2066","article-title":"The kinase IKK\u03b1 inhibits activation of the transcription factor NF-\u03baB by phosphorylating the regulatory molecule TAX1BP1","volume":"12","author":"Shembade","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jhep.2024.08.029_bib45","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1038\/s41467-022-33493-5","article-title":"Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK","volume":"13","author":"Ge","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jhep.2024.08.029_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","article-title":"Specific knockdown of endogenous tau protein by peptide-directed ubiquitin-proteasome degradation","volume":"23","author":"Chu","year":"2016","journal-title":"Cell Chem Biol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824025388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824025388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:09:41Z","timestamp":1778512181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824025388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0168827824025388"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.08.029","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}